David Valeri

Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

P. Meybohm, P. Kranke, C. V. D. van der Kallen, 2022, Trials.

Development of molecular resist derivatives for EUV lithography

David Valeri, Michael B. Clark, Mike Wagner, 2013, Advanced Lithography.